Indication of Sentinel node Biopsy in cancer breast
**Core Concept**
Sentinel node biopsy (SNB) is a diagnostic procedure used to identify the first lymph node to which cancer cells are likely to spread from a primary tumor. In the context of breast cancer, it is employed to assess the axillary lymph nodes for metastasis.
**Why the Correct Answer is Right**
The sentinel node is identified using a radioactive tracer and/or a blue dye, which is injected near the tumor site. The sentinel node is then removed and examined for cancer cells. If the sentinel node is negative, it is less likely that the remaining lymph nodes in the axilla are involved. This information helps determine the extent of lymph node dissection required, thus avoiding unnecessary removal of lymph nodes and associated complications. The sentinel node biopsy is particularly useful in patients with early-stage breast cancer, as it helps tailor the surgical approach and potentially reduces the risk of lymphedema.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because sentinel node biopsy is not typically indicated in patients with distant metastasis or stage IV breast cancer. In such cases, the focus shifts to systemic therapy rather than localized treatment.
**Option B:** This option is incorrect because sentinel node biopsy is not primarily used for diagnostic purposes in patients with known lymph node involvement. Its primary value lies in identifying the sentinel node in patients without clinically apparent lymph node metastasis.
**Option C:** This option is incorrect because sentinel node biopsy is not typically indicated in patients with inflammatory breast cancer. This aggressive subtype of breast cancer often requires more extensive surgical resection and systemic therapy.
**Clinical Pearl / High-Yield Fact**
The sentinel node biopsy is a valuable tool in breast cancer management, allowing for targeted axillary dissection and minimizing the risk of lymphedema. However, it is essential to select patients carefully, as the procedure may not be suitable for all patients with breast cancer.
**Correct Answer: C. Not indicated in inflammatory breast cancer.**